| Literature DB >> 22145118 |
Taha S El-Alfy1, Hamida M A El-Gohary, Nadia M Sokkar, Mohammed Hosny, Dalia A Al-Mahdy.
Abstract
A major development over the past two decades has been the realization that free radical induced lipid peroxidation and DNA damage are associated with major health problems, e.g. cancer and ageing. Plant-derived antioxidants are increasingly found beneficial in protecting against these diseases. Celtis australis L. and Celtis occidentalis L. are two plants that have a variety of uses in folk medicine but have not been evaluated before for their antioxidant and cytotoxic properties. Therefore, the extracts of both plants' leaves were investigated for these activities, as well as isolation of the bioactive compounds responsible for the activities. Molecular structures of the compounds were elucidated by UV, HRESIMS, 1D ((1)H and (13)C) and 2D ((1)H-(13)C HSQC and (1)H-(13)C HMBC) NMR analyses. The ethanolic and aqueous extracts, n-butanol fractions and the isolated major compound were tested for their antioxidant activity using DPPH radical scavenging assay, xanthine oxidase-induced generation of superoxide radical and lipid peroxidation assay by thiobarbituric acid-reactive substances (TBARS) method using rat tissue homogenates. Cytotoxic activities were studied using standard MTT assay. A novel flavonoid C-triglycoside, 4‴-α-rhamnopyranosyl-2″-O-β-d-galactopyranosylvitexin, was isolated from both plants' leaves, together with seven known flavonoids. The n-butanol fractions and the major compound 2″-O-β-galactopyranosylvitexin showed significant antioxidant activities, more pronounced than the tested standards BHT and dl-α-tocopherol in most tests. All extracts showed variable cytotoxic activities. This study provides strong evidence for the antioxidant and cytotoxic activities of the extracts of Celtis australis L. and Celtis occidentalis L. leaves, which were attributed to the polar n-butanol fractions and the major isolated flavonoid 2″-galactosylvitexin.Entities:
Keywords: Celtis australis L.; Celtis occidentalis L.; Cytotoxic activities; DPPH; Flavonoid C-glycosides; Lipid peroxidation; Xanthine oxidase
Year: 2011 PMID: 22145118 PMCID: PMC3221499 DOI: 10.3797/scipharm.1108-19
Source DB: PubMed Journal: Sci Pharm ISSN: 0036-8709
Effects of the tested samples on the in vitro free radical generation
| Bioassay | DPPH % inhibition | Xanthine oxidase |
|---|---|---|
| Ethanolic extract (CA) | 67.2 ± 2.10 | 76.8 ± 2.90 |
| Ethanolic extract (CO) | 58.5 ± 1.50 | 92.1 ± 3.55 |
| Aqueous extract (CA) | 55.6 ± 2.10 | 70.2 ± 2.18 |
| Aqueous extract (CO) | 48.5 ± 1.35 | 95.5 ± 3.70 |
| 70.3 ± 2.20 | 27.2 ± 2.10 | |
| 65.9 ± 1.96 | 38.5 ± 1.78 | |
| 2″- | 84.8 ± 2.44 | 24.2 ± 1.95 |
| 66.5 ± 2.75 | 78.5 + 2.88 | |
| BHT | 55.3 ± 1.50 | 130.7 + 4.35 |
| Allopurinol | – | 18.0 ± 0.25 |
Uric acid production for controls was (61.0 ± 1.9 nmol/min).
All tested samples and positive controls were tested at 100 μg/mL.
Values are presented as mean ± SE of 3-test sample observation. P < 0.05 for all values.
CA = Celtis australis L.; CO = Celtis occidentalis L.
Inhibition effects of the tested samples on FeSO4/H2O2-stimulated lipid peroxidation (MDA production) in rat tissue homogenates in vitro
| Bioassay | Inhibition (%) | ||
|---|---|---|---|
| Sample | Brain | Heart | Liver |
| Ethanolic extract (CA) | 80.85 ± 1.15 | 55.30 ± 1.80 | 68.30 ± 1.83 |
| Ethanolic extract (CO) | 75.60 ± 1.97 | 50.22 ± 1.80 | 70.90 ± 2.15 |
| Aqueous extract (CA) | 55.10 ± 2.28 | 52.40 ± 2.18 | 43.90 ± 2.25 |
| Aqueous extract (CO) | 43.50 ± 1.55 | 48.75 ± 1.28 | 32.75 ± 1.80 |
| 66.18 ± 2.10 | 54.10 ± 1.80 | 49.75 ± 1.76 | |
| 64.82 ± 2.05 | 60.05 ± 1.85 | 53.10 ± 1.80 | |
| 2″- | 80.78 ± 3.12 | 71.50 ± 2.35 | 78.25 ± 3.10 |
| 62.90 ± 2.18 | 58.70 ± 1.80 | 71.10 ± 2.25 | |
| BHT | 52.48 ± 1.72 | 43.23 ± 1.65 | 53.20 ± 1.65 |
Values are presented as mean ± SE of 3-test sample observations, P < 0.05 for all values;
200 μg/mL;
100 μg/mL; CA = Celtis australis L.; CO = Celtis occidentalis L.
ED50 (μg/mL) of the tested samples on the selected cell linesa
| Sample | HEP-G2 | CCRF-CEM | COLO 205 | NCI-N87 | NIH-OVAR-3 |
|---|---|---|---|---|---|
| Ethanolic extract (CA) | 26.10 ± 0.20 | > 100 | 25.65 ± 0.20 | 45.15 ± 0.25 | 77.65 ± 0.52 |
| Ethanolic extract (CO) | 39.85 ± 0.25 | > 100 | 24.80 ± 0.20 | 15.80 ± 0.05 | 68.50 ± 0.45 |
| Aqueous extract (CA) | 26.90 ± 0.20 | 77.50 ± 0.53 | 63.45 ± 0.40 | 35.10 ± 0.15 | 72.77 ± 0.48 |
| Aqueous extract (CO) | 18.60 ± 0.08 | 79.54 ± 0.47 | 26.60 ± 0.25 | 23.55 ± 0.10 | 76.10 ± 0.55 |
Values are presented as mean ± SE of 2 test sample observation, compared with that of control group (p < 0.05) for all values; HEP-G2…Human hepatocellular carcinoma; CCRF-CEM…leukemia carcinoma; COLO 205…colon adenocarcinoma; NIH-OVCAR-3…ovary adenocarcinoma; NCI-N87…gastric carcinoma; CA…Celtis australis L.; CO…Celtis occidentalis L.
1H and 13C NMR data of compound 8 (DMSO-d6, 300, 75 MHz)
| No. | Compound 8
| No. | Compound 8
| ||
|---|---|---|---|---|---|
| δH | δH | No. | |||
| 2 | 163.7 | 3″ | 75.8 | ||
| 3 | 6.70, s | 102.5 | 4″ | 70.8 | |
| 4 | 182.0 | 5″ | 81.5 | ||
| 5 | 160.1 | 6″ | 61.1 | ||
| 6 | 6.21, s | 97.9 | 2″- | 3.99, d (9) | 101.4 |
| 7 | 162.4 | 2‴ | 72.3 | ||
| 8 | 104.3 | 3‴ | 74.0 | ||
| 9 | 156.3 | 4‴ | 67.2 | ||
| 10 | 103.9 | 5‴ | 75.0 | ||
| 1′ | 121.8 | 6‴ | 58.1 | ||
| 2′ | 8.01, d (8.7) | 128.8 | 4‴- | 4.90, s | 100.2 |
| 3′ | 6.89, d (9) | 115.8 | 2″″ | 70.4 | |
| 4′ | 160.9 | 3″″ | 70.6 | ||
| 5′ | 6.89, d (9) | 115.8 | 4″″ | 73.2 | |
| 6′ | 8.01, d (8.7) | 128.8 | 5″″ | 68.1 | |
| 8- | 4.76, d (9.9) | 71.7 | 6″″ | 1.19, d (6) | 17.5 |
| 2″ | 78.9 | ||||
Coupling constants (J in Hertz) are in parentheses.